ETHENESULFONAMIDE 729An analytical sample was obtained by crystallization of the crude material from benzene followed by 3 recrystallizations from ethyl acetate. It softened at 150°and melted at 192.5-194.0°.A mixed melting point of 2-quinoxalinoformamide and 2acetamidoquinoxaline (m.p. 192.6-193.8°)12 showed a sharp depression.3',4'-Dichloroformanilide. Acetic formic anhydride was prepared from acetic anhydride (40.8 ml.) and 98% formic acid (17.2 ml.). This mixture was cooled in an ice bath to 12°. A gradual addition of 3,4-dichloroaniline (32.4 g., 0.2 mole) was made so that the temperature did not rise above 40°. The dark red solution was held at room temperature (35°) for five hours after which ether (100 ml.) was added. The following day the dark purple solution was extracted with 2 X 100 ml. of water. The ether layer was evaporated on the steam bath to furnish 36.7 g. (96.5%) of crude material, m.p. 94-103°. A hot benzene (150 ml.) solution of the crude product was treated with Nuchar C. The filtrate was cooled for several hours prior to collecting the product by filtration. A cold benzene wash was applied to the gray solid. The purified 3',4'-dichloroformanilide weighed 30.4 g. It sintered at 99°and melted at 110-112°. Recrystallization from a large volume of carbon tetrachloride furnished off-white crystals with no change in melting point. The product is soluble in chloroform and cyclohexene but insoluble in petroleum ether or cyclohexane. Possibly a reduction in the quantity of acetic formic anhydride to slightly over one mole would give a satisfactory result for this type of preparation. Skokie, III.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.